Insider · CIK 0002086494
Zuraiz Chaudhary
Files at TTRX (Turn Therapeutics Inc.). First filing Oct 23, 2025, latest Dec 12, 2025.
In brief
Zuraiz Chaudhary files SEC Form 4 as officer at TTRX (Turn Therapeutics Inc.). Since Oct 23, 2025, Zuraiz Chaudhary has reported 4 open-market buys worth $50k and 0 open-market sells worth $0, the latest filed on Dec 12, 2025.
A track record needs three past buys with six months of prices behind them; Zuraiz Chaudhary has 0, so none is measured yet.
The newest scored trade: bought $8,750 of TTRX on Dec 12, 2025, filed Dec 12, 2025, scored 26 (weak). In the last 12 months: 4 buys worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TTRX: Turn Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | TTRXbuy Turn Therapeutics Inc. | $8,750 2,500 shares | +25% | - | |
| 34Weak | Turn Therapeutics Inc. | $7,075 2,450 shares | +32% | - | |
| 34Weak | Turn Therapeutics Inc. | $9,050 2,500 shares | +50% | - | |
| 38Weak | Turn Therapeutics Inc. | $25k 5,050 shares | - | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | TTRX Turn Therapeutics Inc. | AGrant or award Employee stock option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 3, 2026 |
| Dec 12, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +2,500 | $3.50 | $8,750 | 12,500 | Dec 12, 2025 |
| Nov 20, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +1,450 | $2.61 | $3,785 | 9,000 | Nov 21, 2025 |
| Nov 21, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +1,000 | $3.29 | $3,290 | 10,000 | Nov 21, 2025 |
| Nov 17, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +2,500 | $3.62 | $9,050 | 7,550 | Nov 17, 2025 |
| Oct 23, 2025 | TTRX Turn Therapeutics Inc. | POpen-market purchase Common Stock | +5,050 | $4.95 | $25k | 5,050 | Oct 23, 2025 |
| Oct 8, 2025 | TTRX Turn Therapeutics Inc. | AGrant or award Employee stock option (right to buy)derivative | +240,000 | $0.00 | $0 | 240,000 | Oct 10, 2025 |
Questions about Zuraiz Chaudhary
Answered from the filings on this page, as of the latest one.
Is Zuraiz Chaudhary buying or selling?
In the last 12 months Zuraiz Chaudhary reported 4 open-market buys worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $8,750 of TTRX on Dec 12, 2025. Grants, option exercises and tax withholding are not counted.
How did Zuraiz Chaudhary's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Zuraiz Chaudhary has 0.
Where does Zuraiz Chaudhary file Form 4?
Zuraiz Chaudhary has filed Form 4 at TTRX (Turn Therapeutics Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.